Anti-infective antibodies: finding the path forward.
Baker
Monya
M
D000900:Anti-Bacterial Agents / Q000096:biosynthesis / Q000276:immunology*; D000918:Antibody Specificity / Q000276:immunology; D001424:Bacterial Infections / Q000276:immunology / Q000517:prevention & control*; D002986:Clinical Trials as Topic; D015195:Drug Design; D007116:Immunization, Passive / Q000379:methods*; D007136:Immunoglobulins / Q000096:biosynthesis / Q000494:pharmacology*; D016106:Methicillin Resistance / Q000187:drug effects / Q000276:immunology; D013211:Staphylococcus aureus / Q000187:drug effects / Q000276:immunology; D014611:Vaccination / Q000379:methods*
D000900:Anti-Bacterial Agents; D007136:Immunoglobulins